CuraTeQ Biologics announces Phase1 clinical study outcome of BP11 product March 18, 2024 CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, announced that their Omalizumab biosimilar candidate BP11 has met the Phase 1 trial end points vis-à-vis the EU and US sourced reference... Trending Diarrhea main killer of kids under 5, adults above 70: Study How children “look” at their social environment could help predict autism diagnosis Doctors oppose non-MBBS faculty, stage protest Latest Diarrhea main killer of kids under 5, adults above 70: Study Healthy population fuels productivity, drives economic growth: Union Health Secretary NEET-UG exam soon to shift from offline to online, NTA to undergo re-structuring What is textationship: New age Romance of New Generation
